rs375045076

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001367624.2(ZNF469):​c.4472C>T​(p.Thr1491Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00357 in 1,549,392 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0025 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0037 ( 16 hom. )

Consequence

ZNF469
NM_001367624.2 missense

Scores

1
2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:9

Conservation

PhyloP100: 0.137
Variant links:
Genes affected
ZNF469 (HGNC:23216): (zinc finger protein 469) This gene encodes a zinc-finger protein. Low-percent homology to certain collagens suggests that it may function as a transcription factor or extra-nuclear regulator factor for the synthesis or organization of collagen fibers. Mutations in this gene cause brittle cornea syndrome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009863615).
BP6
Variant 16-88431942-C-T is Benign according to our data. Variant chr16-88431942-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 281900.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Benign=1, Uncertain_significance=4}. Variant chr16-88431942-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00246 (375/152268) while in subpopulation NFE AF= 0.00441 (300/68022). AF 95% confidence interval is 0.004. There are 1 homozygotes in gnomad4. There are 153 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 16 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF469NM_001367624.2 linkc.4472C>T p.Thr1491Met missense_variant Exon 3 of 3 ENST00000565624.3 NP_001354553.1
ZNF469XM_047434810.1 linkc.4472C>T p.Thr1491Met missense_variant Exon 4 of 4 XP_047290766.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF469ENST00000565624.3 linkc.4472C>T p.Thr1491Met missense_variant Exon 3 of 3 6 NM_001367624.2 ENSP00000456500.2 H3BS19
ZNF469ENST00000437464.1 linkc.4388C>T p.Thr1463Met missense_variant Exon 2 of 2 5 ENSP00000402343.1 Q96JG9

Frequencies

GnomAD3 genomes
AF:
0.00246
AC:
375
AN:
152150
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000566
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00441
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.00191
AC:
292
AN:
153134
Hom.:
1
AF XY:
0.00205
AC XY:
167
AN XY:
81390
show subpopulations
Gnomad AFR exome
AF:
0.000759
Gnomad AMR exome
AF:
0.00130
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000878
Gnomad FIN exome
AF:
0.000828
Gnomad NFE exome
AF:
0.00393
Gnomad OTH exome
AF:
0.00138
GnomAD4 exome
AF:
0.00369
AC:
5153
AN:
1397124
Hom.:
16
Cov.:
97
AF XY:
0.00356
AC XY:
2454
AN XY:
689138
show subpopulations
Gnomad4 AFR exome
AF:
0.000601
Gnomad4 AMR exome
AF:
0.00140
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000379
Gnomad4 FIN exome
AF:
0.00102
Gnomad4 NFE exome
AF:
0.00453
Gnomad4 OTH exome
AF:
0.00255
GnomAD4 genome
AF:
0.00246
AC:
375
AN:
152268
Hom.:
1
Cov.:
33
AF XY:
0.00205
AC XY:
153
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.000914
Gnomad4 AMR
AF:
0.00177
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.000566
Gnomad4 NFE
AF:
0.00441
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00351
Hom.:
0
Bravo
AF:
0.00235
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00471
AC:
15
ExAC
AF:
0.00133
AC:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:5
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ZNF469: BP4, BS2 -

Jul 22, 2015
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jun 16, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26582918) -

Brittle cornea syndrome 1 Uncertain:2
Mar 20, 2018
Baylor Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1Benign:1
Dec 16, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: ZNF469 c.4472C>T (p.Thr1491Met) results in a non-conservative amino acid change in the encoded protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0019 in 153134 control chromosomes, predominantly at a frequency of 0.0039 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygote. c.4472C>T has been reported in the literature (example: Lucas_2017). This report however, does not provide unequivocal conclusions about association of the variant with Brittle cornea syndrome 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 29228253). ClinVar contains an entry for this variant (Variation ID: 281900). Based on the evidence outlined above, the variant was classified as likely benign. -

Jul 05, 2016
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Jun 14, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Feb 20, 2019
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ZNF469-related disorder Benign:1
Aug 04, 2020
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
16
DANN
Benign
0.32
DEOGEN2
Benign
0.011
T;.
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.044
N
LIST_S2
Benign
0.52
T;.
M_CAP
Pathogenic
0.83
D
MetaRNN
Benign
0.0099
T;T
MetaSVM
Benign
-0.94
T
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.17
N;N
REVEL
Benign
0.041
Sift
Uncertain
0.016
D;D
Sift4G
Uncertain
0.021
D;D
Vest4
0.086
MVP
0.19
ClinPred
0.013
T
GERP RS
2.3
gMVP
0.063

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375045076; hg19: chr16-88498350; COSMIC: COSV71258398; API